• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCuranex Pharmaceuticals
    Picture of Curanex Pharmaceuticals logo

    CURX — Curanex Pharmaceuticals News Story

    $4.640.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $7.28m
    • Enterprise Value
      $4.34m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CURX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CURX Dividends
    All News

    NASDAQ RESUMED AT 09:00 AM

    Picture of Curanex Pharmaceuticals logoCuranex Pharmaceuticals
    20/08/2026 14:00
    NASDAQ RESUMED  AT 09:00 AM

    Recent news on Curanex Pharmaceuticals

    See all news
    • Brief: Curanex Pharmaceuticals - Securities Class Action Filed Against Curanex Pharmaceuticals And Underwriters On July 23, 2026 - SEC Filing

      19/10/2026 23:10
    • NASDAQ RESUMED AT 09:00 AM

      20/08/2026 14:00
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

      20/08/2026 08:58
    • NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

      20/08/2026 24:50
    • Brief: Curanex Pharmaceuticals Advancing Phyto-N Toward A Planned Investigational New Drug Submission To FDA For Ulcerative Colitis In Q4 2026

      14/05/2026 14:05

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.